Further, a VLCKD improves inflammation, reducing TNF-alpha, PAI-1, IL-6, IL-8 and MCP-1, which are strongly involved in the pathophysiology of cardiovascular diseases and obesity [41]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.